Physician profile
Ashley E Young
NPI 1336623099
$3,169.99
in general payments reported to CMS, 2019-2025
9 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $327 · 2022: $556 · 2023: $331 · 2024: $64.45 · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386 · Travel and Lodging: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.36 |
| Travel and Lodging | $900.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,995.81 | 2021-2025 | Barostim Neo System |
| Abbott Laboratories | $426.86 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $271.25 | 2023 | Impella |
| Medtronic, INC. | $217.67 | 2021-2023 | Cobalt Dr Mri Surescan |
| Bridgebio Pharma, INC. | $142.05 | 2025 | Attruby |
| Atricure, INC. | $44.97 | 2024 | |
| Novo Nordisk INC | $33.99 | 2025 | Wegovy |
| Daxor Corporation | $19.48 | 2024 | Bva-100 |
| Myovant Sciences INC. | $17.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.